Inotiv, Inc. to Report Fiscal 2024 First Quarter Financial Results and Host Conference Call on Wednesday, February 7, 2024

Rhea-AI Summary

Inotiv, Inc. (NOTV) will release its fiscal 2024 first-quarter financial results on February 7, 2024, after the stock market closes. The company will host a conference call to discuss the results at 4:30 p.m. Eastern Time on the same day. Interested parties can participate by dialing the provided numbers or accessing the live conference call webcast on the company's website. An online replay will also be available for those unable to listen to the live broadcast.

WEST LAFAYETTE, Ind., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2024 first quarter ended December 31, 2023, on Wednesday, February 7, 2024, after the close of the stock market. The Company will host a conference call that same day at 4:30 p.m. Eastern Time to discuss the results.

Interested parties may participate in the call by dialing:

• (877) 704-4453 (Domestic)
• (201) 389-0920 (International)
• 13744155 (Conference ID)
  

The live conference call webcast will be accessible in the Investors section of the Company’s web site and directly via the following link:

https://callme.viavid.com/viavid/?callme=true&passcode=13742881&h=true&info=company-email&r=true&B=6

For those who cannot listen to the live broadcast, an online replay will be available in the Investors section of Inotiv’s web site at: https://www.inotivco.com/investors/investor-information/.

About Inotiv
Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotivco.com/.

This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the impact of recent events related to non-human primate matters on the Company’s business, operations, results, financial condition, cash flows, and assets, the Company’s ability to comply with covenants under its credit agreement, changes in the market and demand for the Company’s products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, governmental regulations, inspections and investigations, claims and litigation against or involving the Company, its business and/or its industry, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.

Company Contact	Investor Relations
Inotiv, Inc.	LifeSci Advisors
Beth A. Taylor, Chief Financial Officer	Bob Yedid
(765) 497-8381	(516) 428-8577
btaylor@inotivco.com	bob@lifesciadvisors.com

When will Inotiv release its fiscal 2024 first-quarter financial results?

Inotiv will release its fiscal 2024 first-quarter financial results on February 7, 2024, after the stock market closes.

What time will the conference call to discuss the results be held?

The conference call to discuss the results will be held at 4:30 p.m. Eastern Time on February 7, 2024.

How can interested parties participate in the conference call?

Interested parties can participate in the conference call by dialing (877) 704-4453 for Domestic or (201) 389-0920 for International, using the Conference ID 13744155.

Where can the live conference call webcast be accessed?

The live conference call webcast will be accessible in the Investors section of the Company’s website and directly via the following link: https://callme.viavid.com/viavid/?callme=true&passcode=13742881&h=true&info=company-email&r=true&B=6

Will an online replay of the conference call be available?

Yes, an online replay of the conference call will be available in the Investors section of Inotiv’s website at: https://www.inotivco.com/investors/investor-information/